DCI
Data Collective IV’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.1M | Hold |
5,941,120
| – | – | 23.14% | 3 |
|
|
2025
Q1 | $31.4M | Hold |
5,941,120
| – | – | 36.17% | 1 |
|
|
2024
Q4 | $40.2M | Hold |
5,941,120
| – | – | 17.75% | 2 |
|
|
2024
Q3 | $39.2M | Hold |
5,941,120
| – | – | 23.95% | 3 |
|
|
2024
Q2 | $44.6M | Hold |
5,941,120
| – | – | 31.23% | 2 |
|
|
2024
Q1 | $59.2M | Hold |
5,941,120
| – | – | 51.36% | 1 |
|
|
2023
Q4 | $58.6M | Hold |
5,941,120
| – | – | 48.46% | 1 |
|
|
2023
Q3 | $45.4M | Hold |
5,941,120
| – | – | 43% | 2 |
|
|
2023
Q2 | $44.4M | Hold |
5,941,120
| – | – | 32.86% | 2 |
|
|
2023
Q1 | $39.6M | Hold |
5,941,120
| – | – | 42.23% | 1 |
|
|
2022
Q4 | $45.8M | Hold |
5,941,120
| – | – | 48.11% | 1 |
|
|
2022
Q3 | $63.2M | Hold |
5,941,120
| – | – | 49.97% | 1 |
|
|
2022
Q2 | $48.4M | Hold |
5,941,120
| – | – | 39.94% | 1 |
|
|
2022
Q1 | $42.5M | Hold |
5,941,120
| – | – | 9.03% | 2 |
|
|
2021
Q4 | $102M | Buy |
+5,941,120
| New | +$102M | 13.74% | 2 |
|